194 related articles for article (PubMed ID: 26045764)
21. Knockdown of farnesylpyrophosphate synthase prevents angiotensin II-mediated cardiac hypertrophy.
Ye Y; Mou Y; Bai B; Li L; Chen GP; Hu SJ
Int J Biochem Cell Biol; 2010 Dec; 42(12):2056-64. PubMed ID: 20884373
[TBL] [Abstract][Full Text] [Related]
22. SP1-induced SNHG14 aggravates hypertrophic response in in vitro model of cardiac hypertrophy via up-regulation of PCDH17.
Long Y; Wang L; Li Z
J Cell Mol Med; 2020 Jul; 24(13):7115-7126. PubMed ID: 32436661
[TBL] [Abstract][Full Text] [Related]
23. Upregulation of lncRNA VDR/CASC15 induced by facilitates cardiac hypertrophy through modulating miR-432-5p/TLR4 axis.
Li C; Zhou G; Feng J; Zhang J; Hou L; Cheng Z
Biochem Biophys Res Commun; 2018 Sep; 503(4):2407-2414. PubMed ID: 29966657
[TBL] [Abstract][Full Text] [Related]
24. RIP2 deficiency attenuates cardiac hypertrophy, inflammation and fibrosis in pressure overload induced mice.
Zhao CH; Ma X; Guo HY; Li P; Liu HY
Biochem Biophys Res Commun; 2017 Nov; 493(2):1151-1158. PubMed ID: 28698147
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-26a protects against cardiac hypertrophy via inhibiting GATA4 in rat model and cultured cardiomyocytes.
Liu Y; Wang Z; Xiao W
Mol Med Rep; 2016 Sep; 14(3):2860-6. PubMed ID: 27485101
[TBL] [Abstract][Full Text] [Related]
26. Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis.
Okada K; Minamino T; Tsukamoto Y; Liao Y; Tsukamoto O; Takashima S; Hirata A; Fujita M; Nagamachi Y; Nakatani T; Yutani C; Ozawa K; Ogawa S; Tomoike H; Hori M; Kitakaze M
Circulation; 2004 Aug; 110(6):705-12. PubMed ID: 15289376
[TBL] [Abstract][Full Text] [Related]
27. Attenuation of microRNA-16 derepresses the cyclins D1, D2 and E1 to provoke cardiomyocyte hypertrophy.
Huang S; Zou X; Zhu JN; Fu YH; Lin QX; Liang YY; Deng CY; Kuang SJ; Zhang MZ; Liao YL; Zheng XL; Yu XY; Shan ZX
J Cell Mol Med; 2015 Mar; 19(3):608-19. PubMed ID: 25583328
[TBL] [Abstract][Full Text] [Related]
28. Zinc-finger protein 418 overexpression protects against cardiac hypertrophy and fibrosis.
Pan L; Sheng M; Huang Z; Zhu Z; Xu C; Teng L; He L; Gu C; Yi C; Li J
PLoS One; 2017; 12(10):e0186635. PubMed ID: 29065170
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of farnesyl pyrophosphate synthase attenuates angiotensin II-induced cardiac hypertrophy and fibrosis in vivo.
Yang J; Zhu HH; Chen GP; Ye Y; Zhao CZ; Mou Y; Hu SJ
Int J Biochem Cell Biol; 2013 Mar; 45(3):657-66. PubMed ID: 23277274
[TBL] [Abstract][Full Text] [Related]
30. Long Noncoding RNA
Yu J; Yang Y; Xu Z; Lan C; Chen C; Li C; Chen Z; Yu C; Xia X; Liao Q; Jose PA; Zeng C; Wu G
Circ Heart Fail; 2020 Jan; 13(1):e006525. PubMed ID: 31957467
[TBL] [Abstract][Full Text] [Related]
31. MicroRNAs are dynamically regulated in hypertrophic hearts, and miR-199a is essential for the maintenance of cell size in cardiomyocytes.
Song XW; Li Q; Lin L; Wang XC; Li DF; Wang GK; Ren AJ; Wang YR; Qin YW; Yuan WJ; Jing Q
J Cell Physiol; 2010 Nov; 225(2):437-43. PubMed ID: 20458739
[TBL] [Abstract][Full Text] [Related]
32. Polyphyllin I attenuates pressure over-load induced cardiac hypertrophy via inhibition of Wnt/β-catenin signaling pathway.
Li Q; Jiang W; Wan Z; Ni Y; Lei L; Wei J
Life Sci; 2020 Jul; 252():117624. PubMed ID: 32259602
[TBL] [Abstract][Full Text] [Related]
33. HOTAIR functions as a competing endogenous RNA to regulate PTEN expression by inhibiting miR-19 in cardiac hypertrophy.
Lai Y; He S; Ma L; Lin H; Ren B; Ma J; Zhu X; Zhuang S
Mol Cell Biochem; 2017 Aug; 432(1-2):179-187. PubMed ID: 28316060
[TBL] [Abstract][Full Text] [Related]
34. Polydatin prevents hypertrophy in phenylephrine induced neonatal mouse cardiomyocytes and pressure-overload mouse models.
Dong M; Ding W; Liao Y; Liu Y; Yan D; Zhang Y; Wang R; Zheng N; Liu S; Liu J
Eur J Pharmacol; 2015 Jan; 746():186-97. PubMed ID: 25449040
[TBL] [Abstract][Full Text] [Related]
35. Ablation of lncRNA
Yang L; Deng J; Ma W; Qiao A; Xu S; Yu Y; Boriboun C; Kang X; Han D; Ernst P; Zhou L; Shi J; Zhang E; Li TS; Qiu H; Nakagawa S; Blackshaw S; Zhang J; Qin G
Theranostics; 2021; 11(16):7995-8007. PubMed ID: 34335976
[No Abstract] [Full Text] [Related]
36. Requirement of nuclear factor-kappaB in angiotensin II- and isoproterenol-induced cardiac hypertrophy in vivo.
Freund C; Schmidt-Ullrich R; Baurand A; Dunger S; Schneider W; Loser P; El-Jamali A; Dietz R; Scheidereit C; Bergmann MW
Circulation; 2005 May; 111(18):2319-25. PubMed ID: 15870116
[TBL] [Abstract][Full Text] [Related]
37. Puerarin attenuates pressure overload-induced cardiac hypertrophy.
Yuan Y; Zong J; Zhou H; Bian ZY; Deng W; Dai J; Gan HW; Yang Z; Li H; Tang QZ
J Cardiol; 2014 Jan; 63(1):73-81. PubMed ID: 23906530
[TBL] [Abstract][Full Text] [Related]
38. Novel role for caspase-activated DNase in the regulation of pathological cardiac hypertrophy.
Gao L; Huang K; Jiang DS; Liu X; Huang D; Li H; Zhang XD; Huang K
Hypertension; 2015 Apr; 65(4):871-81. PubMed ID: 25646292
[TBL] [Abstract][Full Text] [Related]
39. Up-regulation of SNHG16 induced by CTCF accelerates cardiac hypertrophy by targeting miR-182-5p/IGF1 axis.
Wang D; Lin B; Zhang W; Wang X
Cell Biol Int; 2020 Jul; 44(7):1426-1435. PubMed ID: 32125046
[TBL] [Abstract][Full Text] [Related]
40. Pressure overload-induced cardiac hypertrophy response requires janus kinase 2-histone deacetylase 2 signaling.
Ying H; Xu MC; Tan JH; Shen JH; Wang H; Zhang DF
Int J Mol Sci; 2014 Nov; 15(11):20240-53. PubMed ID: 25380525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
